Polymerase Chain Reaction Market
Polymerase Chain Reaction Market Study by PCR Instruments, Standard PCR Systems, RT PCR Systems, Digital PCR Systems, PCR Reagents, and PCR Consumables from 2024 to 2034
Analysis of Polymerase Chain Reaction Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Polymerase Chain Reaction Market Outlook (2024 to 2034)
The global polymerase chain reaction market size is expected to attain a valuation of US$ 6.2 billion in 2024. Projected to expand at a CAGR of 10%, worldwide sales of polymerase chain reaction products are foreseen to reach US$ 16 billion by 2034.
The dreadful impact of SARS-CoV-2 surged the need for reliable and rapid detection systems such as quantitative polymerase chain reaction (qPCR). It is the gold standard for detecting the novel coronavirus, owing to its higher specificity and sensitivity than other tests.
Mounting prevalence of chronic and infectious diseases is leading to the increasing application of polymerase chain reaction (PCR) solutions. Technological advancements and substantial investments in pharmaceutical and healthcare industries are pushing polymerase chain reaction market growth toward a more positive trajectory.
Developing economies are expected to offer substantial growth opportunities for PCR product suppliers, led by the intensifying incidence of infectious and chronic diseases, along with soaring R&D initiatives to develop innovative genomic techniques such as PCR. Also, market growth is set to be reinforced by the expansion of healthcare infrastructure across regions, upsurge in healthcare expenditure, and reducing procedural costs for qPCR-based and dPCR-based disease diagnosis in several countries.
Developing economies are beholding rapid modernization and expansion of healthcare facilities. This factor is contributing to the growing demand for clinical diagnostic procedures among diagnostic laboratories, which is resulting in the rising sales of clinical PCR products. Consequently, a surge in pharmaceutical R&D budgets by governments and private organizations is also expected to boost the development of advanced rapid medical diagnostic kits such as real-time polymerase chain reaction (RT-PCR) molecular diagnostics.
Development of RT-qPCR kits that can detect SARS-CoV-2, coupled with their wide acceptance globally to detect corona variants, is mainly driving their sales growth.
| Report Attribute | Detail |
|---|---|
| Polymerase Chain Reaction Market Size (2024E) | US$ 6.2 Billion |
| Forecasted Market Value (2034F) | US$ 16 Billion |
| Global Market Growth Rate (2024 to 2034) | 10% CAGR |
| Japan Market Value (2034F) | US$ 1.1 Billion |
| RT-PCR System Demand Growth (2024 to 2034) | 10.7% CAGR |
| Digital PCR System Sales (2034F) | US$ 2.6 Billion |
| PCR Reagent Sales (2024E) | US$ 1.1 Billion |
| Key Companies Profiled | Bio-Rad Laboratories Inc.; Stilla; Standard BioTools; Siemens Healthineers; BioMerieux S.A; Danaher Corporation; Thermo Fisher Scientific Inc.; Qiagen N.V; Becton Dickinson & Company (BD); Abbott Laboratories; Agilent Technologies; F. Hoffmann-La Roche Ltd.; Microsynth AG. |
Which Polymerase Chain Reaction Market Trends are Increasing Profits of Manufacturers?
“Efficiency of PCR Analysis Increasing its Importance in Diagnostic Field”
PCR technology sales growth is primarily being driven by the rising incidence of target diseases and genetic disorders, continuous technological advancements in PCR diagnostic systems, development of miniaturized portable instruments, and incorporation of robotics, increasing use of biomarker profiling for disease diagnostics, and grants for research activities,
Demand for genomic analysis techniques is gaining traction on the back of microbial identification and detection of genetic mutation’s increasing use in the diagnosis of major infectious diseases such as tuberculosis, HIV, malaria, hepatitis, Staph-related diseases, and genetic disorders such as cancer and fragile X syndrome. Additionally, with the proven efficacy of PCR analysis in the diagnosis and estimation of disease-causing microbes, demand for clinical diagnostic tests including qPCR and dPCR analysis is set to increase at a high pace.
What is Limiting Adoption of Smart PCR Systems?
“High Cost of Advanced PCR Technologies”
High cost associated with advanced polymerase chain reaction technologies such as qPCR and digital PCR is acting as a deterrent to their adoption. Current costs associated with qPCR devices are on the higher side. The price of an advanced PCR detection system ranges from US$ 4,000 to US$ 13,000 or more depending on add-on features. Digital PCR instruments are more expensive than RT-PCR systems. As such, these high costs of advanced PCR technologies are limiting their use, especially in developing economies.
Start-Up Ecosystem
- Nuclein is a United States-based start-up that offers point-of-care diagnostic solutions. The company’s 'Nuclein Anywhere', a polymerase chain reaction (PCR) test, is an effective home-based self-testing solution.
- SAGA Diagnostics is a Sweden-based start-up that makes use of dPCR for cancer detection. The company’s non-invasive in-vitro diagnostic kit 'SAGAsafe' can make accurate detection of multiple types of cancer.
Country-wise Analysis
What’s Fuelling Demand for Polymerase Chain Reaction Technologies in the United States?
“Advanced Diagnostic Solutions through Extensive R&D Investments”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 700 Million |
| Growth Rate (2024 to 2034) | 10.5% CAGR |
| Projected Value (2034F) | US$ 1.8 Billion |
The United States is foreseen to remain the kingpin and account for 45.6% of the North American polymerase chain reaction market share by 2034. Demand for PCR systems is being driven by the presence of advanced healthcare infrastructure and increasing penetration of cutting-edge diagnostic technologies, including PCR systems for research and clinical applications. The adoption of novel biotechnologies, rising awareness about PCR products, and significant fund allocation for research in national budgets are key factors driving market growth in the United States.
Will Polymerase Chain Reaction Technology Providers Witness Positive Growth in Japan?
“Japan Emerging Market for PCR Technologies in East Asia”
| Attribute | Japan |
|---|---|
| Market Value (2024E) | US$ 400 Million |
| Growth Rate (2024 to 2034) | 10.5% CAGR |
| Projected Value (2034F) | US$ 1.1 Billion |
Growing awareness among physicians and healthcare professionals about the benefits of gene-based disease diagnosis and treatment is increasing the importance of PCR systems in Japan. Moreover, growing public-private support to develop novel PCR technologies is set to account for a particularly high growth rate for the market in the country.
Category-wise Analysis
What is Increasing Use of PCR Systems in Pharmaceutical and Biotechnology Sectors?
“Investments in R&D for Genetic Engineering”
| Attribute | Pharmaceutical and Biotechnology Industries |
|---|---|
| Segment Value (2024E) | US$ 2.2 Billion |
| Growth Rate (2024 to 2034) | 10.2% CAGR |
| Projected Value (2034F) | US$ 5.7 Billion |
Pharmaceutical and biotechnology companies are poised to capture a big chunk of the global market share by 2034-end. Snowballing test volumes and laboratory automation are projected to increase the demand for PCR services in the pharmaceutical and biotechnology industries.
Gigantic strides made in the domain of pharmacogenomics and the rising trend of self-diagnosis of ailments are expected to push PCR kit sales. Burgeoning investments in R&D of genetic engineering and competition in the discovery of new drugs for diseases such as HIV-AIDS and cancer are also set to increase the use of PCR technologies in pharma and biotech institutions.
Clinical diagnostic labs and hospitals are also making high use of PCR technologies. RT-PCR systems are aiding healthcare specialists in carrying out quick diagnoses and make effective treatment decisions.
What is Augmenting Sales of PCR Reagents?
“Need for Improved PCR Reagents for Quick Diagnosis”
| Attribute | PCR Reagents |
|---|---|
| Segment Value (2024E) | US$ 1.1 Billion |
| Growth Rate (2024 to 2034) | 10.6% CAGR |
| Projected Value (2034F) | US$ 2.9 Billion |
Continuously increasing number of diagnostic tests and the launch of new reagents specific to the test type are set to augment the demand for reagents used in polymerase chain reactions. Increasing importance of molecular and point-of-care diagnostics will result in higher reliance on PCR reagents.
- In March 2021, PCR Biosystems announced the launch of its IsoFast Bst Polymerase reagents that support sensitive, robust, and rapid amplification of RNA and DNA, which enables fast testing procedures.
PCR instruments are also set to exhibit high demand growth over the coming years. Increasing risk of contagious diseases, with many leading to fatalities, is driving the demand for advanced PCR instruments in healthcare facilities.
Competitive Landscape
Key players in the polymerase chain reaction market are embracing innovative approaches such as technological advancements, mergers, and acquisitions to expand their footprint.
- In January 2024, Seegene Inc., a South Korean producer of PCR molecular diagnostics solutions, declared its technological collaboration with Microsoft for its SG OneSystemTM business model.
- In 2021, United States-based Thermo Fisher Scientific, provider of scientific instrumentation, reagents, and consumables, introduced the Applied Biosystem QuantStudio Absolute Q-Digital PCR System, the first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results in genetic analysis and research within 90 minutes.
Fact.MR provides detailed information about the price points of key producers of polymerase chain reaction products across the world, sales growth, production capacity, and speculative technological expansion, in the recently updated market report.
Key Segments of Polymerase Chain Reaction Market Research
-
By Product :
- PCR Instruments
- Standard PCR Systems
- RT PCR Systems
- Digital PCR Systems
- PCR Reagents
- PCR Consumables
-
By End User :
- Pharmaceutical & Biotechnology Industries
- Clinical Diagnostics Labs & Hospitals
- Academic & Research Organizations
-
By Region :
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 6.1. Product
- 6.2. End User
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Product
- 7.1. PCR Instruments
- 7.2. Standard PCR Systems
- 7.3. RT PCR Systems
- 7.4. Digital PCR Systems
- 7.5. PCR Reagents
- 7.6. PCR Consumables
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End User
- 8.1. Pharmaceutical & Biotechnology Industries
- 8.2. Clinical Diagnostics Labs & Hospitals
- 8.3. Academic & Research Organizations
- 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Western Europe
- 9.4. Eastern Europe
- 9.5. East Asia
- 9.6. South Asia & Pacific
- 9.7. Middle East & Africa
- 10. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 11. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 12. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 13. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 14. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 15. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 16. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 17. Sales Forecast 2024 to 2034 by Product, End User, and Region for 30 Countries
- 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 19. Company Profile
- 19.1. Bio-Rad Laboratories Inc.
- 19.2. Stilla
- 19.3. Standard BioTools
- 19.4. Siemens Healthineers
- 19.5. BioMerieux S.A
- 19.6. Danaher Corporation
- 19.7. Thermo Fisher Scientific Inc.
- 19.8. Qiagen N.V
- 19.9. Becton Dickinson & Company (BD)
- 19.10. Abbott Laboratories
- 19.11. Agilent Technologies
- 19.12. F. Hoffmann-La Roche Ltd.
- 19.13. Microsynth AG
- 20. Assumptions and Acronyms Used
- 21. Research Methodology
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by Region, 2019 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 10: North America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 11: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 12: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 13: North America Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 14: North America Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 16: North America Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 17: North America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 19: Latin America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 20: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 21: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 22: Latin America Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 23: Latin America Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 24: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 25: Latin America Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 26: Latin America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 28: Western Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 29: Western Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 30: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 31: Western Europe Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 32: Western Europe Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 33: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 34: Western Europe Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 35: Western Europe Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 36: Western Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 37: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 38: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 39: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 40: Eastern Europe Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 41: Eastern Europe Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 42: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 43: Eastern Europe Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 44: Eastern Europe Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 45: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 46: East Asia Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 47: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 48: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 49: East Asia Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 50: East Asia Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 52: East Asia Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 53: East Asia Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 55: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 56: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 57: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 58: South Asia & Pacific Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 59: South Asia & Pacific Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 60: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 61: South Asia & Pacific Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 62: South Asia & Pacific Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 63: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 64: MEA Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 65: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 66: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 67: MEA Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 68: MEA Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 69: MEA Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 70: MEA Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 71: MEA Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 72: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Product, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Product, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by End User, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by End User, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 14: North America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 15: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 16: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 17: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 18: North America Market Share Analysis by Country, 2024 & 2034
Figure 19: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 20: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 21: North America Market Share and BPS Analysis by Product, 2024 & 2034
Figure 22: North America Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Product, 2024 to 2034
Figure 24: North America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 25: North America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 27: Latin America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 28: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 29: Latin America Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 30: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 31: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 32: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 33: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 34: Latin America Market Share and BPS Analysis by Product, 2024 & 2034
Figure 35: Latin America Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 36: Latin America Market Attractiveness Analysis by Product, 2024 to 2034
Figure 37: Latin America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 38: Latin America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 39: Latin America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 40: Western Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 41: Western Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 42: Western Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 43: Western Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 44: Western Europe Market Share Analysis by Country, 2024 & 2034
Figure 45: Western Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 46: Western Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 47: Western Europe Market Share and BPS Analysis by Product, 2024 & 2034
Figure 48: Western Europe Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 49: Western Europe Market Attractiveness Analysis by Product, 2024 to 2034
Figure 50: Western Europe Market Share and BPS Analysis by End User, 2024 & 2034
Figure 51: Western Europe Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 52: Western Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 53: Eastern Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 54: Eastern Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 55: Eastern Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 56: Eastern Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 57: Eastern Europe Market Share Analysis by Country, 2024 & 2034
Figure 58: Eastern Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 59: Eastern Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 60: Eastern Europe Market Share and BPS Analysis by Product, 2024 & 2034
Figure 61: Eastern Europe Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 62: Eastern Europe Market Attractiveness Analysis by Product, 2024 to 2034
Figure 63: Eastern Europe Market Share and BPS Analysis by End User, 2024 & 2034
Figure 64: Eastern Europe Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 65: Eastern Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 66: East Asia Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 67: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 68: East Asia Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 69: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 70: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 71: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 72: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 73: East Asia Market Share and BPS Analysis by Product, 2024 & 2034
Figure 74: East Asia Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 75: East Asia Market Attractiveness Analysis by Product, 2024 to 2034
Figure 76: East Asia Market Share and BPS Analysis by End User, 2024 & 2034
Figure 77: East Asia Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 78: East Asia Market Attractiveness Analysis by End User, 2024 to 2034
Figure 79: South Asia & Pacific Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 80: South Asia & Pacific Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 81: South Asia & Pacific Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 82: South Asia & Pacific Market Incremental $ Opportunity, 2024 to 2034
Figure 83: South Asia & Pacific Market Share Analysis by Country, 2024 & 2034
Figure 84: South Asia & Pacific Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 85: South Asia & Pacific Market Attractiveness Analysis by Country, 2024 to 2034
Figure 86: South Asia & Pacific Market Share and BPS Analysis by Product, 2024 & 2034
Figure 87: South Asia & Pacific Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 88: South Asia & Pacific Market Attractiveness Analysis by Product, 2024 to 2034
Figure 89: South Asia & Pacific Market Share and BPS Analysis by End User, 2024 & 2034
Figure 90: South Asia & Pacific Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 91: South Asia & Pacific Market Attractiveness Analysis by End User, 2024 to 2034
Figure 92: MEA Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 93: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 94: MEA Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 95: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 96: MEA Market Share Analysis by Country, 2024 & 2034
Figure 97: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 98: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 99: MEA Market Share and BPS Analysis by Product, 2024 & 2034
Figure 100: MEA Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 101: MEA Market Attractiveness Analysis by Product, 2024 to 2034
Figure 102: MEA Market Share and BPS Analysis by End User, 2024 & 2034
Figure 103: MEA Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 104: MEA Market Attractiveness Analysis by End User, 2024 to 2034
- FAQs -
How big is the polymerase chain reaction market?
The global polymerase chain reaction market is approximated at US$ 6.2 billion in 2024.
How much will the PCR industry be worth by 2034?
The market for polymerase chain reaction products is calculated to reach US$ 16 billion by 2034.
What is the estimated CAGR for the global market?
Demand for PCR products is foreseen to rise at a CAGR of 10% during the study period (2024 to 2034).
Which region is expected to exhibit high demand for polymerase chain reaction technologies?
Sales of polymerase chain reaction systems in North America are forecasted to reach US$ 3.9 billion by 2034.
What are the sales projections for polymerase chain reaction instruments?
Revenue from polymerase chain reaction instruments is evaluated at US$ 1.1 billion in 2024.
How much share Japan is anticipated to hold in the East Asia market?
Japan is estimated to account for 28.9% of the East Asia market share in 2024.
Who are the leading producers of polymerase chain reaction products?
Some of the leading market players are Siemens Healthineers, BioMerieux S.A, Danaher Corporation, Thermo Fisher Scientific Inc., and Qiagen N.V.
Polymerase Chain Reaction Market